SCHEMBL2826537

SCHEMBL2826537

CCC(O)(CC(=O)N1C(=O)O[C@@H](c2ccccc2)[C@H]1c1ccccc1)c1ccnc(OC)c1COCc1ccccc1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2826531 1.00 IDH1 (0.31) IDH1
SCHEMBL2801659 0.80 SLC13A5 (0.42)
SCHEMBL2801656 0.80 SLC13A5 (0.42)
SCHEMBL2800491 0.73 IDH1 (0.32) IDH1
SCHEMBL2798693 0.67 SLC13A5 (0.42)
SCHEMBL2798702 0.67 SLC13A5 (0.42)
SCHEMBL2799544 0.66 IDH1 (0.32) IDH1
SCHEMBL2799853 0.64 RAB9A (0.43)
SCHEMBL6762164 0.62 ACSS2 (0.32)
SCHEMBL5509747 0.62 L3MBTL1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168426-A1 NOVEL PROCESSES FOR THE PRODUCTION OF USEFUL INTERMEDIATES IPSEN/S.C.R.A.S. (ANDRE BOURGOUIN) (FR) 2010-07-01 US disclosed
US-7705155-B2 Processes for the production of useful intermediates SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (FR) 2010-04-27 US disclosed
US-20090247563-A9 Novel Processes for the Production of Useful Intermediates IPSEN/S.C.R.A.S. (ANDRE BOURGOUIN) (FR) 2009-10-01 US disclosed
US-20070167475-A1 Novel Processes for the Production of Useful Intermediates IPSEN/S.C.R.A.S. (ANDRE BOURGOUIN) (FR) 2007-07-19 US disclosed
EP-1794127-A1 NOVEL PROCESSES FOR THE PRODUCTION OF USEFUL INTERMEDIATES Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) (FR) 2007-06-13 EP disclosed
WO-2006033011-A1 NOVEL PROCESSES FOR THE PRODUCTION OF USEFUL INTERMEDIATES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUE (S.C.R.A.S.) (FR) 2006-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167475-A1 Novel Processes for the Production of Useful Intermediates PGD, TALDO1, COASY IDH1 62/4885
US-20090247563-A9 Novel Processes for the Production of Useful Intermediates PGD, TALDO1, COASY IDH1 62/4885
US-20100168426-A1 NOVEL PROCESSES FOR THE PRODUCTION OF USEFUL INTERMEDIATES PGD, TALDO1, COASY IDH1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.